# Mounjaro's half-life, in plain words

> Mounjaro's half-life is about 5 days, with steady levels after 4 weekly doses. What that means, what the label doesn't say, and a calm way to keep your record.

Canonical page: https://handlehealth.co/mounjaro-half-life · Category: Guides · Last checked against sources: 2026-09-23

The Mounjaro half-life is about 5 days, according to its US prescribing information, and it is what allows one injection a week. Zepbound is the same medicine, tirzepatide. Here is what the figure means, how levels build over the first four weeks, what the labels say about how long tirzepatide stays in your system, and who to ask about pregnancy plans or surgery.

## In short

- Mounjaro's half-life, the time it takes for the amount of tirzepatide in the body to fall by half, is about 5 days, which its US label says enables once-weekly dosing; the Zepbound label, for the same medicine, gives about 5 to 6 days in people with overweight or obesity.[1][2]
- After each injection, tirzepatide reaches its highest level within 8 to 72 hours, and with once-weekly injections it reaches a steady state after 4 weeks.[1][2]
- Neither US label says how long tirzepatide stays in the body after the last dose; for pregnancy planning, UK guidance from the MHRA lists a wash-out of at least 1 month for tirzepatide, to plan with your prescriber.[3]
- A half-life is not a schedule: what to do about a late or missed dose, a pregnancy or an operation is for your prescriber, pharmacist or surgical team to decide with you.
- Handle's Between doses, a Premium feature in the iPhone app, draws an estimated level curve only from the doses you have recorded; it never draws a future dose and is not dose advice.

## What the Mounjaro half-life means

Half-life is the time it takes for the amount of a medicine in your body to fall by half. For tirzepatide, the medicine in Mounjaro, the US label gives an elimination half-life of about 5 days and says this is what enables once-weekly dosing.[1]

The reason is built into the molecule. Tirzepatide carries a fatty-acid chain that binds it to albumin, a protein in the blood, and the label says this prolongs its half-life; about 99% of it circulates bound to albumin.[1] The result is a once-weekly injection, given at any time of day, with or without meals.[1]

A half-life is an average from studies, not a measurement of you. It says nothing about how well the medicine is working for you, and it isn't an instruction about when to inject.

### Zepbound half-life vs Mounjaro

Same medicine, same maker, same once-weekly injection. The Zepbound label gives a half-life of about 5 to 6 days in people with overweight or obesity, and in people with obstructive sleep apnea and obesity; its overdosage section uses about 5 days.[2]

In the UK and EU there is no Zepbound: tirzepatide for weight management is sold as Mounjaro, which the MHRA authorized for that use in November 2023.[5] Compare the two US brands in [Mounjaro vs Zepbound](https://handlehealth.co/mounjaro-vs-zepbound).

## Tirzepatide levels at a glance: what the labels say

The pharmacokinetic facts from the two US labels, in one place. They describe how the medicine behaves on average; none of them is an instruction.

|  | What the Mounjaro and Zepbound labels say |
|---|---|
| Half-life | About 5 days (Mounjaro); about 5 to 6 days in people with overweight or obesity (Zepbound)[1][2] |
| Highest level after a dose | 8 to 72 hours after the injection; Zepbound's label gives a median of 24 hours[1][2] |
| Steady state | Reached after 4 weeks of once-weekly injections[1][2] |
| Share absorbed from the injection | About 80%[1][2] |
| Injection site | Similar exposure from the abdomen, thigh or upper arm[1] |
| Why it lasts | A fatty-acid chain binds it to albumin in the blood (about 99% bound), which prolongs the half-life[1] |
| Stomach emptying | Slowed; the delay is largest after the first dose and lessens over time[1][2] |
| How long it stays after the last dose | Not stated in either US label |

*From sections 12.1 to 12.3 of each label.[1][2] Where to inject is covered in [Mounjaro injection sites](https://handlehealth.co/mounjaro-injection-sites).*

## How tirzepatide levels rise and settle

What the labels describe, step by step. It is how the medicine behaves on average, not a plan for any dose.

- **8 to 72 hours — The peak.** After an injection under the skin, tirzepatide reaches its highest level within 8 to 72 hours; Zepbound's label gives a median of about a day.[1][2]
- **Through the week — A slow fall.** With a half-life of about 5 days, the level comes down gradually over the rest of the week.[1]
- **Weeks 1 to 4 — Building up.** Because the half-life is close to the week between doses, some of each dose is still there when the next one arrives, so levels build over the first weeks.
- **From week 4 — Steady state.** The labels say steady levels are reached after 4 weeks of once-weekly injections: from then on, while the dose stays the same, each week's rise and fall follows much the same pattern.[1][2]

*Figures from the Mounjaro and Zepbound prescribing information.[1][2] Handle's Between doses, a Premium feature in the iPhone app, draws an estimate from your own recorded doses instead of this general picture.*

### Between doses: an estimate from your own record (Handle Premium)

Between doses turns the Mounjaro or Zepbound doses you have recorded, with their dates and times, into an estimated tirzepatide level curve, using the medicine's published half-life and absorption figures.

It is a model, not a blood test. It only draws doses you have already taken, never a future dose, and it never suggests a dose or a time to take one: your prescriber sets those.

- Drawn only from doses you recorded
- Published half-life and absorption figures for tirzepatide
- No future doses and no timing suggestions
- Labeled as an estimate, never a measurement

## How long does Mounjaro stay in your system?

The honest answer: the US labels don't give a number. They give the half-life, the time to peak and the time to steady state, but no time for tirzepatide to clear after the last injection.[1][2]

That sets tirzepatide apart from semaglutide, the medicine in Ozempic and Wegovy, whose labels do say how long it stays in the circulation after the last dose.[6][7] See [Ozempic half-life](https://handlehealth.co/ozempic-half-life). If you see a figure for tirzepatide elsewhere, check whether it comes from a label or is a calculation from the half-life. A calculation from an average can't tell you about your own body.

The UK regulator does give tirzepatide a time frame, but for pregnancy planning; see below.[3]

## Mounjaro half-life vs Ozempic and other GLP-1 medicines

Label half-lives side by side. A half-life says how long a medicine lasts in the body, not how well it works, so these figures don't rank the medicines.

| Medicine | Brands | Half-life | Taken |
|---|---|---|---|
| Tirzepatide | Mounjaro, Zepbound | About 5 days; 5 to 6 in people with overweight or obesity[1][2] | Injection, once a week |
| Semaglutide | Ozempic, Wegovy | About 1 week[6][7] | Injection, once a week |
| Semaglutide, by mouth | Wegovy pill, Rybelsus, Ozempic tablets | About 1 week[7][8] | Tablet, once a day |
| Orforglipron | Foundayo | About 29 to 49 hours[9] | Tablet, once a day |

*From each medicine's US prescribing information. More on semaglutide in [Ozempic half-life](https://handlehealth.co/ozempic-half-life), on [whether there is a Mounjaro pill](https://handlehealth.co/is-there-a-mounjaro-pill), and on the head-to-head trial of the two weekly injections in [semaglutide vs tirzepatide](https://handlehealth.co/semaglutide-vs-tirzepatide).*

## Pregnancy plans and surgery: what the guidance says

In both situations below, the timing is a clinical decision. Here is what the labels and the UK regulator say, so you can raise it early.

### If you're planning a pregnancy

UK guidance from the MHRA says GLP-1 medicines should not be taken during pregnancy or just before trying to get pregnant, and advises contraception while taking them and for a "wash-out" period afterwards. It lists that period as at least 1 month for tirzepatide (Mounjaro) and at least 2 months for semaglutide.[3]

In the US, the Zepbound label says weight loss is not recommended during pregnancy and advises stopping Zepbound once a pregnancy is recognized.[2] Both tirzepatide labels also say the medicine may make the contraceptive pill less effective, and advise a non-oral method, or an added barrier method, for 4 weeks after starting and after each dose increase.[1][2]

If a pregnancy is possible or planned, tell your prescriber early; if you think you might already be pregnant, the MHRA says to speak to a healthcare professional straight away.[3] The timing is something to plan with them, not to work out from a half-life.

### If you have surgery or a procedure coming up

Tirzepatide slows stomach emptying, and the US labels report rare cases of pulmonary aspiration (stomach contents entering the lungs) in people on GLP-1 medicines under general anesthesia or deep sedation, despite fasting as instructed. They say there isn't enough data to know whether changing fasting instructions or temporarily stopping the medicine would lower that risk, and ask you to tell your healthcare providers before any planned surgery or procedure.[1][2]

In the UK, the MHRA asks anaesthetists to make an individualised assessment of the risk, and advises patients not to stop treatment without first discussing it with their doctor.[4] So tell your surgeon and anesthesiologist (anaesthetist in the UK) that you take Mounjaro, and let them decide what, if anything, changes.

> **What the half-life can't decide for you**
> - **When to take a late or missed dose.** Mounjaro and Zepbound each have their own rule in their instructions for use, so ask your prescriber or pharmacist. Handle records what happened and never tells you to catch up.
> - **Whether to change your injection day, your dose or your medicine.** Those are your prescriber's decisions.
> - **Your own level.** Label figures are averages from studies; nothing here, or in Handle, measures what is in your blood.
> - **The timing around a pregnancy or an operation.** Your prescriber and surgical team plan that with you.

### Every dose, with the time you actually took it (in Handle)

Handle records each Mounjaro or Zepbound dose as it happened: the amount, the date and time, and the injection site. Forgot to log one? Add it later, up to 30 days back, and it keeps its real date.

That record answers what a half-life can't, such as when your last dose was, if a surgeon or pharmacist asks. More in our [Mounjaro tracker](https://handlehealth.co/mounjaro-tracker) and [Zepbound tracker](https://handlehealth.co/zepbound-tracker) guides.

- Amount, time and site in one entry
- A reminder on your injection day in the iPhone app, if you want one
- Journey draws your dose as a step line beneath your weight trend
- No streaks, no scores and no dose advice

## Questions to bring to your prescriber or pharmacist

The half-life explains the weekly rhythm. These questions cover the decisions it can't make.

1. What should I do if I'm late with a dose or miss one? (Mounjaro's instructions have a specific rule; ask rather than guess.)
2. I'm planning a pregnancy, or might become pregnant: when should we talk about stopping, and which contraception suits me until then?
3. I have surgery or a procedure coming up: who needs to know, and will anything change?
4. Could Mounjaro affect how my other medicines work, such as the contraceptive pill?
5. If my dose or medicine changes, what should I watch for and record in the weeks after?

Getting ready for an appointment? See [preparing for a GLP-1 doctor appointment](https://handlehealth.co/glp-1-doctor-appointment). For what the labels report about side effects, see [Mounjaro side effects](https://handlehealth.co/mounjaro-side-effects).

## Questions people ask

### What is the half-life of Mounjaro?

About 5 days. Mounjaro's US prescribing information gives tirzepatide an elimination half-life of approximately 5 days and says this is what enables once-weekly dosing.[1] Half-life is the time it takes for the amount of a medicine in the body to fall by half. It is an average from studies, not a measurement of your own level.

### How long does Mounjaro stay in your system?

The US labels don't say. They give tirzepatide's half-life, about 5 days, or 5 to 6 in people with overweight or obesity, and steady levels after 4 weeks of weekly doses, but no time to clear after the last injection.[1][2] For pregnancy planning, UK MHRA guidance lists a wash-out of at least 1 month for tirzepatide; plan that with your prescriber.[3]

### What is the half-life of Zepbound?

About 5 to 6 days in people with overweight or obesity, according to Zepbound's US label, which uses about 5 days in its overdosage section.[2] Zepbound and Mounjaro are the same medicine, tirzepatide, from Eli Lilly, and both labels describe steady levels after 4 weeks of once-weekly injections.[1][2] Compare the brands in [Mounjaro vs Zepbound](https://handlehealth.co/mounjaro-vs-zepbound).

### Does Mounjaro build up in your system?

Over the first few weeks, yes, and then it levels off. The labels say tirzepatide reaches a steady state after 4 weeks of once-weekly injections; from then on, while the dose stays the same, each week's rise and fall follows much the same pattern.[1][2] Steady state describes the level of medicine in the blood, not a result, and it isn't a reason to change anything on your own.

### When does Mounjaro peak after an injection?

Within 8 to 72 hours, according to the Mounjaro label; Zepbound's label gives a median of 24 hours.[1][2] The level then falls slowly through the week. The label doesn't tie the injection to a time of day: Mounjaro can be given at any time, with or without meals.[1] Handle never suggests timing a dose around the peak.

### Is there a Mounjaro half-life chart or calculator?

Not here, on purpose. A generic calculator can't know your record, and a chart of future doses slides easily into a dosing plan, which is your prescriber's job. Handle's Between doses, a Premium feature in the iPhone app, draws an estimated curve only from doses you have recorded. It's a model, not a blood test, and it never draws a future dose.

### Do I need to tell my surgeon I take Mounjaro?

Yes. The US labels ask you to tell your healthcare providers before any planned surgery or procedure, because tirzepatide slows stomach emptying and rare cases of aspiration under anesthesia have been reported with GLP-1 medicines.[1][2] In the UK, the MHRA advises not stopping treatment without first discussing it with your doctor.[4] Your surgical team decides what, if anything, changes.

### How long after stopping Mounjaro can I get pregnant?

Plan this with your prescriber before you stop. UK MHRA guidance says GLP-1 medicines shouldn't be taken during pregnancy or just before trying to get pregnant, and lists a wash-out of at least 1 month for tirzepatide, with contraception in the meantime.[3] If you think you might already be pregnant, it says to speak to a healthcare professional straight away.[3]

## Sources

1. Eli Lilly and Company, via DailyMed (U.S. National Library of Medicine). [Mounjaro (tirzepatide) injection — Prescribing Information](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d2d7da5d-ad07-4228-955f-cf7e355c8cc0), effective August 27, 2026.
2. Eli Lilly and Company, via DailyMed (U.S. National Library of Medicine). [Zepbound (tirzepatide) injection — Prescribing Information](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=487cd7e7-434c-4925-99fa-aa80b1cc776b), effective August 28, 2026.
3. Medicines and Healthcare products Regulatory Agency (UK). [GLP-1 medicines for weight loss and diabetes: what you need to know](https://www.gov.uk/government/publications/glp-1-medicines-for-weight-loss-and-diabetes-what-you-need-to-know/glp-1-medicines-for-weight-loss-and-diabetes-what-you-need-to-know), updated February 5, 2026.
4. Medicines and Healthcare products Regulatory Agency (UK), Drug Safety Update. [GLP-1 and dual GIP/GLP-1 receptor agonists: potential risk of pulmonary aspiration during general anaesthesia or deep sedation](https://www.gov.uk/drug-safety-update/glp-1-and-dual-gip-slash-glp-1-receptor-agonists-potential-risk-of-pulmonary-aspiration-during-general-anaesthesia-or-deep-sedation), January 28, 2025.
5. Medicines and Healthcare products Regulatory Agency (UK). [MHRA authorises diabetes drug Mounjaro (tirzepatide) for weight management and weight loss](https://www.gov.uk/government/news/mhra-authorises-diabetes-drug-mounjaro-tirzepatide-for-weight-management-and-weight-loss), November 8, 2023.
6. Novo Nordisk, via DailyMed (U.S. National Library of Medicine). [Ozempic (semaglutide) injection — Prescribing Information](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=adec4fd2-6858-4c99-91d4-531f5f2a2d79), effective June 1, 2026.
7. Novo Nordisk, via DailyMed (U.S. National Library of Medicine). [WEGOVY (semaglutide) injection and WEGOVY (semaglutide) tablets — Prescribing Information](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ee06186f-2aa3-4990-a760-757579d8f77b), effective June 18, 2026.
8. Novo Nordisk, via DailyMed (U.S. National Library of Medicine). [RYBELSUS and OZEMPIC (semaglutide) tablets — Prescribing Information](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=27f15fac-7d98-4114-a2ec-92494a91da98), effective January 30, 2026.
9. Eli Lilly and Company, via DailyMed (U.S. National Library of Medicine). [Foundayo (orforglipron) tablets — Prescribing Information](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=8ac446c5-feba-474f-a103-23facb9b5c62), effective July 29, 2026.

## About Handle

Handle is a GLP-1 treatment companion. It keeps your dose record, a short daily check-in, weight, food, drinks and activity in one calm place, and turns them into a summary you can choose to share with your clinician.

Handle supports recording and conversations with your care team. It does not diagnose, and it never tells you to start, change, skip or stop a dose. This page is general information, not medical advice. Always follow your prescriber and your medicine's instructions for use.